Published in Radiology on January 01, 2010
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62
ESR statement on the stepwise development of imaging biomarkers. Insights Imaging (2013) 1.51
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol (2012) 1.45
Evaluation of hepatic cystic lesions. World J Gastroenterol (2013) 1.43
Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39
Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. J Am Coll Surg (2013) 1.38
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol (2010) 1.36
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol (2012) 1.20
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver. Korean J Radiol (2013) 1.07
Liver diffusion-weighted MR imaging: the tower of Babel? Eur Radiol (2010) 1.05
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging (2013) 1.00
Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques. Eur Radiol (2012) 0.99
Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization. Transl Oncol (2014) 0.99
Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol (2012) 0.98
Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases. Radiat Oncol (2011) 0.98
4D flow imaging with MRI. Cardiovasc Diagn Ther (2014) 0.98
In vitro and in vivo repeatability of abdominal diffusion-weighted MRI. Br J Radiol (2012) 0.98
In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. Med Phys (2012) 0.97
Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology (2015) 0.95
Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging (2014) 0.94
Implementation of dual-source RF excitation in 3 T MR-scanners allows for nearly identical ADC values compared to 1.5 T MR scanners in the abdomen. PLoS One (2012) 0.93
Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol (2010) 0.93
Diffusion weighted magnetic resonance imaging and its recent trend-a survey. Quant Imaging Med Surg (2015) 0.93
Characterization of soft tissue masses: can quantitative diffusion weighted imaging reliably distinguish cysts from solid masses? Skeletal Radiol (2013) 0.92
Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am (2011) 0.91
Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features. Stem Cells Int (2015) 0.91
Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. Eur Radiol (2013) 0.90
Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. J Magn Reson Imaging (2014) 0.87
Diffusion-weighted imaging of the liver: usefulness of ADC values in the differential diagnosis of focal lesions and effect of ROI methods on ADC measurements. MAGMA (2012) 0.87
Role of diffusion-weighted imaging in differentiating benign and malignant pediatric abdominal tumors. Pediatr Radiol (2013) 0.87
IVIM Diffusion-weighted Imaging of the Liver at 3.0T: Comparison with 1.5T. Eur J Radiol Open (2015) 0.86
Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging (2016) 0.86
Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study. J Clin Exp Hepatol (2016) 0.85
Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLoS One (2014) 0.85
Motion correction of multi-b-value diffusion-weighted imaging in the liver. Acad Radiol (2012) 0.85
Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility. World J Radiol (2016) 0.84
Intravoxel incoherent motion diffusion imaging of the liver: optimal b-value subsampling and impact on parameter precision and reproducibility. Eur J Radiol (2014) 0.84
Error model for reduction of cardiac and respiratory motion effects in quantitative liver DW-MRI. Magn Reson Med (2012) 0.83
Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues. Korean J Radiol (2016) 0.83
Current management of noninfectious hepatic cystic lesions: A review of the literature. World J Hepatol (2013) 0.83
Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med (2012) 0.83
Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis. PLoS One (2015) 0.82
Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol (2013) 0.82
Diffusion-weighted imaging of the liver: an update. Cancer Imaging (2013) 0.82
Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol (2013) 0.81
Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol (2011) 0.81
Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis. AJR Am J Roentgenol (2014) 0.81
The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach. Eur Radiol (2015) 0.80
Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging. Int J Clin Exp Med (2015) 0.80
Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer. World J Radiol (2011) 0.80
Diffusion-weighted imaging in pediatric body magnetic resonance imaging. Pediatr Radiol (2016) 0.80
Reply to What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease? Inflamm Bowel Dis (2015) 0.79
Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. Eur Radiol (2015) 0.79
Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications. Biomed Res Int (2015) 0.78
Value of hepatic diffusion-weighted magnetic resonance imaging in evaluating liver fibrosis following transarterial chemoembolization with low doses of chemotherapy. Exp Ther Med (2014) 0.78
Grading of small hepatocellular carcinomas (≤2 cm): correlation between histology, T2 and diffusion-weighted imaging. Br J Radiol (2014) 0.78
Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference. Eur Radiol (2013) 0.78
Magnetic resonance imaging of the cirrhotic liver: An update. World J Hepatol (2015) 0.78
Impact of post-processing methods on apparent diffusion coefficient values. Eur Radiol (2016) 0.78
Diffusion-weighted magnetic resonance (DW-MR) neurography of the lumbar plexus in the preoperative planning of lateral access lumbar surgery. Eur Spine J (2014) 0.78
Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol (2013) 0.77
A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI. Magn Reson Med (2016) 0.77
Challenges of advanced hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Impact of field strength and RF excitation on abdominal diffusion-weighted magnetic resonance imaging. World J Radiol (2013) 0.77
The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol (2014) 0.77
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers. Diagnostics (Basel) (2015) 0.77
Integrative role of MRI in the evaluation of primary biliary cirrhosis. Eur Radiol (2011) 0.77
Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging. World J Radiol (2010) 0.77
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response. J Cancer (2016) 0.77
Clinical Advancements in the Targeted Therapies against Liver Fibrosis. Mediators Inflamm (2016) 0.77
Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications. Biomed Res Int (2015) 0.76
Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol (2016) 0.76
Intra-hepatic arterioportal shunt mimicking a metastatic liver tumor: report of a case. Surg Today (2011) 0.76
Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma. Magn Reson Imaging (2016) 0.76
Effect of imaging parameters on the accuracy of apparent diffusion coefficient and optimization strategies. Diagn Interv Radiol (2015) 0.76
Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection. Sci Rep (2016) 0.76
Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging. J Clin Imaging Sci (2013) 0.76
Prognostication and response assessment in liver and pancreatic tumors: The new imaging. World J Gastroenterol (2015) 0.76
Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am (2014) 0.76
Hepatic metastasis complicated by abscess formation. Pak J Med Sci (2015) 0.75
Efficacy of diffusion-weighted magnetic resonance imaging in follow-up patients treated with open partial cystectomy of liver hydatid cysts. Int J Clin Exp Med (2014) 0.75
Assessment of the Focal Hepatic Lesions Using Diffusion Tensor Magnetic Resonance Imaging. J Med Signals Sens (2016) 0.75
Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer. Phys Med Biol (2015) 0.75
Coronal diffusion-weighted magnetic resonance imaging of the kidney: agreement with axial diffusion-weighted magnetic imaging in terms of apparent diffusion coefficient values. Chin Med J (Engl) (2015) 0.75
DWI/ADC in Differentiation of Benign from Malignant Focal Liver Lesion. Acta Inform Med (2016) 0.75
Intra-Individual, Inter-Vendor Comparison of Diffusion-Weighted MR Imaging of Upper Abdominal Organs at 3.0 Tesla with an Emphasis on the Value of Normalization with the Spleen. Korean J Radiol (2016) 0.75
Re: Evaluation of hepatic hemangiomas with diffusion weighted imaging. Korean J Radiol (2013) 0.75
Diffusion-weighted MR imaging of non-complicated hepatic cysts: Value of 3T computed diffusion-weighted imaging. Eur J Radiol Open (2016) 0.75
Diffusion-weighted imaging of pancreatic cancer. World J Radiol (2015) 0.75
Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinoma. Medicine (Baltimore) (2016) 0.75
Value of diffusion-weighted MR imaging for the detection of nephritis. ScientificWorldJournal (2013) 0.75
Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol (2016) 0.75
MRI of paediatric liver tumours: How we review and report. Cancer Imaging (2016) 0.75
Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology (2011) 1.58
Perfusion CT vascular parameters do not correlate with immunohistochemically derived microvessel density count in colorectal tumors. Radiology (2013) 1.46
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging (2008) 1.44
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clin Cancer Res (2012) 1.42
Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations. Radiology (2010) 1.23
Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am (2011) 1.15
Computed diffusion-weighted MR imaging may improve tumor detection. Radiology (2011) 1.10
Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med (2010) 1.06
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma. Radiology (2012) 1.02
Improved intravoxel incoherent motion analysis of diffusion weighted imaging by data driven Bayesian modeling. Magn Reson Med (2013) 1.01
Comparison of free-breathing with navigator-controlled acquisition regimes in abdominal diffusion-weighted magnetic resonance images: Effect on ADC and IVIM statistics. J Magn Reson Imaging (2013) 0.96
Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer. BJU Int (2011) 0.94
Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response. Radiology (2012) 0.90
Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol (2012) 0.90
Optimizing functional parameter accuracy for breath-hold DCE-MRI of liver tumours. Phys Med Biol (2009) 0.88
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib. Radiology (2014) 0.88
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol (2015) 0.87
Informatics in radiology: development of a research PACS for analysis of functional imaging data in clinical research and clinical trials. Radiographics (2012) 0.87
Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI. NMR Biomed (2011) 0.86
Nodal staging. Cancer Imaging (2009) 0.86
Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration. Eur Radiol (2012) 0.86
Imaging studies for germ cell tumors. Hematol Oncol Clin North Am (2011) 0.85
A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. MAGMA (2011) 0.84
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasis. Clin Nucl Med (2015) 0.79
The role of imaging in the diagnosis, staging, and management of testicular cancer. AJR Am J Roentgenol (2008) 0.78
Diagnostic precision of endoanal MRI in the detection of anal sphincter pathology: a meta-analysis. Int J Colorectal Dis (2008) 0.77
Subtraction of unidirectionally encoded images for suppression of heavily isotropic objects (SUSHI) for selective visualization of peripheral nerves. Neuroradiology (2010) 0.76
Functional imaging of the liver. Semin Ultrasound CT MR (2013) 0.75
Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features. Invest Radiol (2017) 0.75
Magnetic Resonance Imaging-Based Assessment of Breast Cancer-Related Lymphoedema Tissue Composition. Invest Radiol (2017) 0.75